The endoplasmic reticulum (ER) is the organelle in which newly synthesized transmembrane and secreted proteins are folded. Proteins that have undergone the steps of conformational maturation, including folding, glycosylation, and intra/intermolecular disulfide bond formation, can be transported to their destination via the Golgi apparatus, but if the proteins have failed to form with the proper conformation, they accumulate in the ER lumen, a condition referred to as ER stress. In order to restore homeostasis in the ER, the cells activate an unfolded protein response (UPR) via activation of three ER transmembrane proteins, referred to as ER stress sensors: activating transcription factor 6 (ATF6), inositol-requiring kinase 1 (IRE1), and protein kinase regulated by RNA-like ER kinase (PERK). This is followed by the activation of specific transcription factors: activated ATF6 for ATF6, XBP1 (x-box binding protein 1) for IRE1, and ATF4 (activating transcription factor 4) for PERK. These transcription factors eventually upregulate the expression of UPR target genes to execute four responses: (i) translational attenuation to limit further protein load at the ER; (ii) enhancement of the capacity of the protein folding system through upregulation of ER chaperones or folding enzymes such as glucose-regulated proteins 78 (GRP78, also known as BiP, immunoglobulin-binding protein) and 94 (GRP94), protein disulfide isomerase (PDI), and ER-localized DnaJ 4 (ERdj4); (iii) facilitation of ER-associated degradation (ERAD), which is accelerated by enhancer mannosidase alpha-like 1 (EDEM1); and, (iv) induction of cellular apoptosis, in which C/EBP homologous protein (CHOP) is thought to play an important role if the adaptive responses (i-iii) are insufficient to relieve ER stress (review in refs. 1 and 2).
In most studies, UPR is induced by treating in vitro cell models with compounds such as tunicamycin, thapsigargin, and dithiothreitol (DTT), which impair the N-linked glycosylation of proteins, 3, 4) the Ca 2þ -dependent chaperone via inhibition of ER Ca 2þ ATPase, 5, 6) and protein disulfide bond formation 7, 8) respectively. Moreover, brefeldin A, an inhibitor of Golgi-specific brefeldin A resistance factor 1 (GBF1), 9, 10) 2-deoxyglucose, an analog of glucose and an inhibitor of N-linked glycosylation, 11) and eeyarestatin I, an inhibitor of ERAD, 12) also have been reported to induce UPR. 10, 13, 14) Since these compounds have different modes of action, the mechanisms of protein accumulation in the ER induced by the various compounds are thought to be different, but it is unclear whether these compounds upregulate all UPR target genes by similar kinetics. Therefore, in order to address our question, we compared the time-course expression profiles of UPR-target genes after treatment with UPRinducing compounds.
First we first selected six compounds commonly used as UPR inducers: 2-deoxyglucose, brefeldin A, DTT, eeyarestatin I, thapsigargin, and tunicamycin. Exploratory chemical screening indicated that monensin induced the expression of GRP78 and other eight UPR-target genes, so this was added as a prospective UPR inducer (see below). We measured the expression of nine UPR target genes, ATF4, CHOP, EDEM1, y To whom correspondence should be addressed. Tel: +81-45-566-1793; Fax: +81-45-566-1557; E-mail: tashiro@bio.keio.ac.jp Abbreviations: ATF4, activating transcription factor 4; ATF6, activating transcription factor 6; CHOP, C/EBP homologous protein; DTT, dithiothreitol; EDEM1, ER degradation enhancer mannosidase alpha-like 1; eIF2, eukaryotic initiation factor 2 ; ER, endoplasmic reticulum; ERAD, ER-associated degradation; ERdj4, ER-localized DnaJ 4; GADD34, growth arrest-and DNA damage-inducible gene 34; GBF1, Golgispecific brefeldin A resistance factor 1; GRP78, glucose-regulated protein 78; GRP94, glucose-regulated protein 94; IRE1, inositol-requiring kinase 1; p58
IPK , protein kinase inhibitor of 58 kDa; PDI, protein disulfide isomerase; PERK, protein kinase regulated by RNA-like ER kinase; RT-PCR, reverse transcription PCR; UPR, unfolded protein response; VSVG, vesicular stomatitis virus G; XBP1, x-box binding protein 1 ERdj4, growth arrest-and DNA damage-inducible gene (GADD) 34, GRP78, GRP94, protein kinase inhibitor of 58 kDa (p58 IPK ), and PDI. GADD34 and p58 IPK have been reported to act as feedback regulators of UPR. 15, 16) The expression profiles of these genes appeared to show characteristic patterns among the compounds. Hierarchical clustering analysis based on the kinetics of the expression of UPR target genes revealed at least two UPR target gene expression profiles, which were dependent on the mode of action of the UPR-inducing compound.
Materials and Methods
Materials. Tunicamycin, 2-deoxyglucose, monensin, and mouse monoclonal anti--actin (AC-74) were purchased from Sigma Aldrich (St. Louis, MO). Brefeldin A and DTT were from Calbiochem (San Diego, CA) and Wako Pure Chemical Industries, (Osaka, Japan) respectively. Thapsigargin and eeyarestatin I were from Santa Cruz Biotechnology (Santa Cruz, CA). Mouse monoclonal anti-KDEL (10C3) was from ENZO Life Sciences (Farmingdale, NY). Rabbit polyclonal anti-eIF2 and anti-phospho eIF2 (Ser51) were from Cell Signaling Technology (Beverly, MA). Rabbit polyclonal anti-PERK was from Rockland (Gilbertsville, PA). Horseradish peroxidaseconjugated anti-mouse IgG secondary antibody was from GE Healthcare (Little Chalfont, UK).
Cell culture. Human epithelial adenocarcinoma cell line HeLa was cultured in Dulbecco's Modified Eagle's Medium (DMEM; Nissui, Tokyo) supplemented with 8% fetal bovine serum at 37 C in a 5% CO 2 -95% air atmosphere.
Western blotting. Western blotting was performed as described previously. 17) Cell pellets were lysed using an extraction buffer containing 150 mM NaCl, 2.5 mM EGTA, 1 mM EDTA, 1 mM DTT, 0.1% Tween-20, 10 mM -glycerophosphate, 1 mM NaF, 0.1 mM Na 3 VO 4 , 10% glycerol, and 50 mM HEPES (pH 7.5). Lysates were separated by 7%-10% SDS-PAGE and then subjected to immunoblotting. This was followed by detection using the ECL Western blotting detection system (Millipore, Bedford, MA) and on LAS-1000 CCD camera (Fujifilm, Tokyo). The visualized bands were quantified using ImageJ software (http://rsb.info.nih.gov/ij/).
Real-time RT-PCR. Reverse transcription was carried out as described previously. 18) Total RNA was extracted from HeLa cells and reverse-transcribed. The synthesized cDNA was subjected to quantitative real-time RT-PCR using SYBR premix Ex Taq (Takara, Shiga, Japan), and was detected using Thermal Cycler Dice Real Time System II (Takara). Data were analyzed using the Smart Cycler software program (Multiplate RQ version 1.00; Takara) by the relative quantification method.
Real-time cycle conditions for ERdj4 were 2 min at 50 C, followed by 10 min at 90 C, and then 45 cycles, each cycle 95 C for 30 s and 63 C for 1 min. The conditions for GAPDH were 10 s at 95 C and then 35 cycles, each of 95 C for 3 s, 60 C for 10 s, and 72 C for 10 s. RT-PCR conditions for all the other genes were 10 s at 95 C and then 40 cycles, each cycle 95 C for 3 s, 60 C for 10 s, and 72 C for 15 s. The sequences of the primer sets are shown in Table S1 (see Biosci. Biotechnol. Biochem. Web site). The amount of total RNA present in each reaction was normalized using GAPDH as internal control. Data are averages of at least three separate experiments, and one outlier was omitted in each case by Dixon's Q-test at the 99% confidence level. 19) RNA interference. siRNA double-stranded oligonucleotides designed to interfere with the expression of PERK (HSS190343; Life Technologies) with siRNA as negative control (12935-300; Life Technologies) were used. Transfection of siRNA was demonstrated using Lipofectamine 2000 (Life Technologies) following the manufacturer's instructions. Briefly, HeLa cells were transfected with OPTI-MEM (Life Technologies) including siRNA and Lipofectamine 2000. Twenty-four h after transfection, the cells were trypsinized and seeded into 6-well plates. After further 24 h, the cells were treated with monensin and subjected to Western blotting.
Data processing and hierarchical clustering. The data acquired were normalized among genes and named ''UPR fingerprints of genes,'' or reordered by compound and named ''UPR fingerprints of compounds.'' Pearson's correlation coefficients between the UPR fingerprints were calculated, and these were used to determine degrees of similarity. Hierarchical clustering by an average linkage method was done using R version 2.13.1. (http://www.R-project.org).
Trypan blue dye exclusion assay. Cell viability was evaluated by trypan blue dye exclusion assay, as described previously.
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Results
Effects of the six UPR-inducing compounds on cell viability and GRP78 and GRP94 protein expression
Our first investigation was to determine suitable concentrations of six compounds (2-deoxyglucose, brefeldin A, DTT, eeyarestatin I, thapsigargin, and tunicamycin) for induction of UPR. GRP78 and GRP94 are well-known UPR marker proteins. Since the anti-KDEL antibody recognizes the KDEL sequence, a very common ER retention signal, it mainly detected both GRP78 and GRP94. Hence, using the anti-KDEL antibody, protein expression of them was examined in HeLa cells after 24-h of treatment with each of the six compounds ( Fig. 1 ). As shown in Fig. 1A , 2-deoxyglucose induced the expression of GRP78 in a dosedependent manner, with an approximately 1.5-fold increase at 0.2 mM and a maximum increase at 2 mM, and neither dose affected cell viability. Similarly, brefeldin A, thapsigargin, and tunicamycin also increased the expression of GRP78 in a dose-dependent manner, with maximum increases at 50 ng/mL, 30 nM, and 10 mg/mL, and with moderate increases (approximately 1.5-fold) at 15 ng/mL, 1 nM, and 1 mg/mL respectively. These doses also failed to affect cell viability (Fig. 1B , E, and F). DTT and eeyarestatin I induced GRP78 expression, at 3 mM and 3 mm respectively ( Fig. 1C and  D) . Additionally, each of the compounds, except for brefeldin A, induced the expression of GRP94 similarly to GRP78, but the intensities of GRP78 and GRP94 protein expression induced by the various compounds were different. Upon treatment by brefeldin A, the expression of GRP94 increased in a dose-dependent manner. It reached a maximum at 50 ng/mL and then declined. Thus, it is likely that the expression patterns and the intensities of GRP78 and GRP94 induction were different among the compounds. In this study, the concentrations sufficient to induce maximum and moderate levels of UPR were defined with reference to the expression of GRP78 as to protein level, as summarized in Table 1 .
Measurement of the time-course expression of the mRNA levels of nine UPR-target genes
To compare the expression patterns of UPR-target genes induced by the six UPR-inducing compounds, first we measured the mRNA levels of GPR78. HeLa cells were treated with one of the six compounds at the concentrations indicated in Table 1 and the amount of GRP78 mRNA was measured by real-time reverse transcription PCR (RT-PCR). As shown in Fig. 2 , all six compounds increased the amount of GRP78 mRNA.
For instance, 30 nM thapsigargin increased it after 4-h of treatment, and it reached a plateau at an approximately 10-fold increase after 12-h of treatment. Two mM 2-deoxyglucose and 10 mg/mL tunicamycin also increased the amount of GRP78 mRNA, which peaked after approximately 12-16 h of treatment, resulting in 20-and 15-fold increases respectively, and then declined by the end of the 24-h treatment period (Fig. 2) . When the cells were treated with 50 ng/mL of brefeldin A, the amount of GRP78 mRNA increased in a time-dependent manner for 24 h, showing an approximately 8-fold rise in expression (Fig. 2) . Taken together, the time-course expression data for GRP78 mRNA appeared to show characteristic patterns among the six compounds.
Moreover, there were similar expression patterns for GRP78 mRNA when the HeLa cells were treated with 15 ng/mL, 50 ng/mL, or 5,000 ng/mL of brefeldin A. Furthermore, when the cells were treated with 0.2 mM and 2 mM of 2-deoxyglucose or 1 nM and 30 nM of thapsigargin, the expression patterns of GRP78 mRNA were also similar. In addition, 1 mg/mL of tunicamycin showed a slightly delayed expression pattern for GRP78 mRNA as compared to 10 mg/mL tunicamycin. Overall, the differences in the concentrations of the compounds did not have any notable effect on the expression patterns of GRP78 mRNA. We further measured the changes in the amount of mRNA of an additional eight UPR target genes, ATF4, CHOP, EDEM1, ERdj4, GADD34, GRP94, PDI, and p58
IPK , when the cells were treated with each of the six compounds. As shown in Supplemental Fig. 1 , all the compounds increased the amounts of the eight UPR target gene mRNA, at the concentrations indicated in Table 1 .
Monensin upregulated UPR target genes
An in-house chemical library, which included commercially available compounds as well as compounds of microbial origin in our laboratory, was screened for additional potential UPR-inducing compounds. It was found that monensin, a compound first isolated from Streptomyces cinnamonensis and known as a Na þ ionophore, 21) increased the amount of GRP78 at protein level with 10 mM treatment (Fig. 3A) without affecting cell viability (Fig. 3B) . Monensin also increased the amount of GRP78 mRNA slightly at 4-24 h of treatment (Fig. 2) , as well as the other eight UPR target genes of interest (Fig. S1) . Furthermore, it induced phosphorylation of eIF2, a well-known substrate of PERK 22) ( Fig. 3C) . Since four kinases (PERK, PKR, HRI, and GCN2) are known to phosphorylate eIF2, we examined to determine whether monensin-induced phosphorylation of eIF2 occurs through PERK activation. As shown in Fig. 3C , monensin-induced phosphorylation of eIF2 was impaired in siPERK-transfected HeLa cells, in which successful knockdown of PERK was confirmed by immunoblotting (Fig. 3C) , suggesting that monensin activated PERK. Thus, it appears that monensin induced UPR, and hence it was used in the remaining experiments in our study.
Clustering of compounds based on the expression profiles of the UPR target genes
It was observed that the kinetics of UPR target gene expression showed characteristic patterns among the 12 experimental conditions tested (seven compounds, some with multiple concentrations). The data acquired were analyzed by hierarchical clustering with the aim of classifying the expression profiles of the UPR target genes. The real-time RT-PCR data for each UPR target gene obtained under the 12 experimental conditions were normalized to acquire UPR fingerprints of genes. Furthermore, the normalized data were reordered by condition in order to acquire UPR fingerprints of compounds (Fig. 4) . Each type of fingerprint was analyzed by hierarchical clustering using Pearson's correlation coefficient as a similarity and averagelinkage method. As a result of clustering analysis of the compounds, as shown on the left side of Fig. 5 , the 12 conditions were divided into two groups: cluster A and cluster B. Cluster A contained thapsigargin, tunicamycin, 2-deoxyglucose, and DTT, and cluster B contained brefeldin A, monensin, and eeyarestatin I. When thapsigargin, tunicamycin, 2-deoxyglucose, or brefeldin A was used at different concentrations, the expression patterns of the UPR target genes were still to be classified in the same cluster. Furthermore, as a result of clustering analysis of the genes, as shown at the top of Fig. 5 , nine genes were classifiable into two groups: cluster I and cluster II (Fig. 5) . Cluster I contained GRP78, ERdj4, EDEM1, p58
IPK , and GRP94, and cluster II contained GADD34, CHOP, PDI, and ATF4. Based on two-way clustering analysis, a heat map displayed the expression data for each gene under each condition by reordering of the data by rows and columns ( Fig. 5) , indicated that the expression intensity of cluster I genes in the fingerprints of cluster A was higher than in cluster B; conversely, the expression intensity of cluster II genes in the fingerprints of cluster A was lower than in cluster B.
Discussion
In this study, by hierarchical clustering analysis, the expression patterns of UPR target genes induced by seven compounds were classified into two clusters.
When cells were treated with thapsigargin, tunicamycin, 2-deoxyglucose, or brefeldin A at different concentrations, the expression patterns of the UPR-target genes were grouped into the same cluster (Fig. 5) . This suggests that this grouping is due to the difference in the modes of action of the compounds, rather than their concentrations. The compounds comprising cluster A, thapsigargin, tunicamycin, 2-deoxyglucose, and DTT, showed a distinct mode of action, but they have been reported to inhibit the conformational maturation of proteins in the ER, 4, [23] [24] [25] [26] as described above in the introduction, leading to an accumulation of incorrectly folded proteins in the ER. On the other hand, among the compounds in cluster B, brefeldin A has been reported to accumulate correctly folded conformation of the vesicular stomatitis virus G (VSVG) protein, as judged by detection by the I14 antibody, which recognizes only the native or correctly folded conformation of the VSVG protein. 27, 28) Thus, it is likely that the compounds in cluster B induced the expression of UPR target genes by accumulation of excess amounts of correctly folded proteins rather than incorrectly folded proteins in the ER. If this is the case, the difference in the expression patterns of UPR target genes as between cluster A and cluster B are related to the folding status of the accumulated proteins in the ER caused by the compounds in cluster A and cluster B. Eeyarestatin I and monensin were classified into cluster B, with the expectation that eeyarestatin I and monensin can accumulate excess amounts of correctly folded proteins in the ER. Indeed, eeyarestatin I has been reported to accumulate properly folded proteins as a consequence of The relative mRNA levels of the genes were normalized by subtracting the average value from the result at each time point and dividing by the standard derivative. A UPR fingerprint of genes was obtained. We created a separate UPR fingerprint of compounds by reordering the data compound-by-compound. Similarities between the two UPR fingerprints (Pearson's correlation coefficient) were calculated and analyzed by hierarchical clustering. ERAD inhibition, detecting properly folded MHC class I by W6/32 antibody, 12, 29) but we cannot exclude the possibility that eeyarestatin I induces UPR through an accumulation of incorrectly folded proteins. On the other hand, monensin has been reported to neutralize acidic intracellular compartments such as the transGolgi apparatus via its ionophore activity, and to inhibit medial-to trans-Golgi protein transport. [30] [31] [32] Hence, we cannot exclude the possibility that inhibition of medialto trans-Golgi protein transport by monensin abrogates the entire protein transport system, including transport from the ER to the Golgi apparatus, resulting in an accumulation of correctly folded proteins in the ER. This possibility was confirmed by our observation that another polyether K þ /H þ ionophore, nigericin, which disrupts Golgi function similarly to monensin, 30, 33) also upregulated GRP78 protein expression (Fig. S2) .
What remains unclear is the reason the compounds in cluster A and cluster B induced different expression patterns of the UPR target genes (Fig. 5 ). As shown in Fig. 5 , the compounds in cluster A and cluster B comparatively highly upregulated the genes belonging to cluster I, GRP78, ERdj4, EDEM1, p58
IPK , and GRP94, and cluster II, GADD34, CHOP, PDI, and ATF4, respectively. Since the expression of a UPR target gene is transcriptionally regulated by the activation of three ER stress sensors (ATF6, IRE1, and PERK), it is possible that each of these stress sensors has distinct sensitivity to compounds belonging to cluster A and cluster B, resulting in higher expression of the genes in cluster I and cluster II respectively. Indeed, it has been reported that GRP94 and GRP78 are regulated by ATF6, 34, 35) ERdj4 is regulated by IRE1, [36] [37] [38] and EDEM1 and p58
IPK are regulated by both IRE1 and ATF6. 34, 37, 38) On the other hand, among the genes to be classified in cluster II, the expression of GADD34 and CHOP was reported to be regulated by PERK. 15, 39, 40) Furthermore, since a previous study found that the PDI gene has a sequence resembling the ATF-binding site in its promoter region, 41) the expression of PDI, a gene in cluster II, might also be mediated by ATF4 and its upstream ER stress sensor, PERK. Thus, it is likely that ATF6 and IRE1 are sensitive to compounds in cluster A in comparison with PERK, and that PERK is sensitive to compounds in cluster B as compared to ATF6 and IRE1. On the other hand, among the compounds in the same cluster, little difference in the expression patterns of the UPR target genes was observed. For instance, tunicamycin highly upregulated p58
IPK and GRP94 as compared to thapsigargin, 2-deoxyglucose, and DTT. 2-Deoxyglucose and DTT highly upregulated GRP78 and ERdj4 as compared to thapsigargin and tunicamycin. In order to compare these differences more clearly, we are developing a new detection system to monitor the activation kinetics of the three ER stress sensors.
In summary, we classified the expression patterns of nine UPR target genes induced by seven UPR-inducing compounds into two clusters by hierarchal clustering analysis. Our results suggest the existence of at least two types of UPR target gene expression profiles, which might be dependent on the mode of action of the compounds. To our knowledge, although there have been many reports on the regulatory mechanism of UPR target gene expression using UPR-inducing compounds, they have failed to address the question whether the difference in mode of action of the UPR-inducing compounds influences the expression patterns of UPR target genes. This study is a first approach this question by statistical analysis, and provides the information that the expression patterns of UPR target genes are indeed different among the compounds. We hypothesize that the sensitivity of the three ER stress sensors depends on the folding status of the accumulated proteins in the ER, which results in the different expression patterns of the UPR target genes. Further study is needed to elucidate our hypothesis that the folding status of the accumulated proteins affects the activation of ER stress sensors, the expression of UPR target genes, and consequent responses, such as protein refolding, protein degradation, and apoptosis.
